Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 2 hours agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 3 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 4 days agoVaccines and Related Biological Products Advisory Committee of the FDA evaluated the effectiveness...
Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the...
CNN via Yahoo News· 4 days agoIn his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 3 days agoThe recommendations follow a recent assessment by the World Health Organization that vaccines should...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 2 days agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA TODAY via Yahoo News· 1 hour agoThe CDC recently reported on June 4 that "COVID-19 infections are growing or likely growing in 30 states." COVID fall vaccine will target ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 18 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 1 day agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 4 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...